Health system intelligence profile
Michigan Medicine / University of Michigan
Last reviewed August 30, 2026
Intelligence summary
Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research. It is organized into three teams: Alliances for industry research relationships, Licensing for intellectual property commercialization, and Ventures for startup formation. The office provides intellectual property strategy, licensing, startup formation and industry engagement support to faculty, staff and student inventors. It also invests directly in university spinouts through the Accelerate Blue Fund, an early-stage venture fund, and publishes annual impact reports going back to 2001.
Documented successes: 28 startup companies created in fiscal year 2024; operates the Accelerate Blue Fund, an early-stage venture fund investing in University of Michigan startups
Mandate and remit
Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research. It is organized into three teams: Alliances for industry research relationships, Licensing for intellectual property commercialization, and Ventures for startup formation. The office provides intellectual property strategy, licensing, startup formation and industry engagement support to faculty, staff and student inventors. It also invests directly in university spinouts through the Accelerate Blue Fund, an early-stage venture fund, and publishes annual impact reports going back to 2001.
These routes appear in the program's sourced public record.
Fund or office: U-M Innovation Partnerships
Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research. It is organized into three teams: Alliances for industry research relationships, Licensing for intellectual property commercialization, and Ventures for startup formation. The office provides intellectual property strategy, licensing, startup formation and industry engagement support to faculty, staff and student inventors. It also invests directly in university spinouts through the Accelerate Blue Fund, an early-stage venture fund, and publishes annual impact reports going back to 2001.
Documented successes
28 startup companies created in fiscal year 2024; operates the Accelerate Blue Fund, an early-stage venture fund investing in University of Michigan startups
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Royal Oak, Michigan
Corewell Health Innovations Office
The Innovations Office is Corewell Health's commercialization arm, housed within the Corewell Health Research Institute in Southeast Michigan, that turns employee and researcher ideas into products, services or licenses.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Grand Rapids, Michigan
Corewell Health Ventures (formerly Spectrum Health Ventures)
Corewell Health Ventures is the venture investment arm of Corewell Health, the integrated Michigan system created by the merger of Spectrum Health and Beaumont Health, which also owns the Priority Health plan.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford Innovations
Henry Ford Innovations advances inventions developed by Henry Ford Health clinicians and researchers while also sourcing external technologies for the system.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford + MSU Innovation Fund (Henry Ford Innovations)
Henry Ford Health and Michigan State University launched a joint Innovation Hub in 2025 anchored by a $10 million venture fund, the Henry Ford + MSU Innovation Fund, managed with the MSU Research Foundation.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Fast Forward Medical Innovation
Michigan Medicine's Fast Forward Medical Innovation (FFMI) is an official biomedical commercialization and entrepreneurship program that describes itself as a front door to biomedical commercialization at the University of Michigan.
Academic
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Coulter Translational Research Partnership Program
The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.